UPR Stock Overview
Operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Uniphar plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.67 |
| 52 Week High | €3.44 |
| 52 Week Low | €1.98 |
| Beta | 0.76 |
| 1 Month Change | 5.54% |
| 3 Month Change | -5.83% |
| 1 Year Change | -18.13% |
| 3 Year Change | -21.15% |
| 5 Year Change | n/a |
| Change since IPO | 127.78% |
Recent News & Updates
Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03
Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Investors Met With Slowing Returns on Capital At Uniphar (ISE:UPR)
Jan 31Uniphar plc's (ISE:UPR) 25% Jump Shows Its Popularity With Investors
Dec 18These 4 Measures Indicate That Uniphar (ISE:UPR) Is Using Debt Reasonably Well
Nov 18The Returns At Uniphar (ISE:UPR) Aren't Growing
Sep 20Uniphar (ISE:UPR) Is Experiencing Growth In Returns On Capital
May 12The Uniphar plc (ISE:UPR) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 03Estimating The Intrinsic Value Of Uniphar plc (ISE:UPR)
Dec 16Here's Why We Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Nov 24An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 45% Undervalued
Aug 01What Does Uniphar plc's (ISE:UPR) Share Price Indicate?
Jul 20Some Investors May Be Worried About Uniphar's (ISE:UPR) Returns On Capital
May 27An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 33% Undervalued
Apr 29Uniphar (ISE:UPR) Seems To Use Debt Quite Sensibly
Apr 02Here's Why I Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Mar 18Uniphar (ISE:UPR) Might Be Having Difficulty Using Its Capital Effectively
Feb 13Is Uniphar (ISE:UPR) A Risky Investment?
Dec 23Here's Why I Think Uniphar (ISE:UPR) Is An Interesting Stock
Oct 30Uniphar's (ISE:UPR) Returns On Capital Not Reflecting Well On The Business
May 14Uniphar (ISE:UPR) Has A Pretty Healthy Balance Sheet
Mar 10Does Uniphar's (ISE:UPR) Share Price Gain of 83% Match Its Business Performance?
Feb 23Will The ROCE Trend At Uniphar (ISE:UPR) Continue?
Feb 02Is Weakness In Uniphar plc (ISE:UPR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 15Trade Alert: The CEO & Executive Director Of Uniphar plc (ISE:UPR), Gerard Rabbette, Has Just Spent €900k Buying 4.2% More Shares
Dec 24
Do Institutions Own Uniphar plc (ISE:UPR) Shares?
Dec 23Is Uniphar (ISE:UPR) Using Too Much Debt?
Dec 03Uniphar (ISE:UPR) Shareholders Have Enjoyed A 91% Share Price Gain
Nov 18Shareholder Returns
| UPR | IE Healthcare | IE Market | |
|---|---|---|---|
| 7D | 1.5% | -0.2% | 0.04% |
| 1Y | -18.1% | -3.1% | 14.2% |
Return vs Industry: UPR underperformed the Irish Healthcare industry which returned -3.1% over the past year.
Return vs Market: UPR underperformed the Irish Market which returned 14.2% over the past year.
Price Volatility
| UPR volatility | |
|---|---|
| UPR Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in IE Market | 6.1% |
| 10% least volatile stocks in IE Market | 2.3% |
Stable Share Price: UPR has not had significant price volatility in the past 3 months.
Volatility Over Time: UPR's weekly volatility (4%) has been stable over the past year, but is still higher than 75% of Irish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 3,000 | Ger Rabbette | www.uniphar.ie |
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.
Uniphar plc Fundamentals Summary
| UPR fundamental statistics | |
|---|---|
| Market cap | €727.59m |
| Earnings (TTM) | €44.82m |
| Revenue (TTM) | €2.55b |
16.2x
P/E Ratio0.3x
P/S RatioIs UPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UPR income statement (TTM) | |
|---|---|
| Revenue | €2.55b |
| Cost of Revenue | €2.16b |
| Gross Profit | €389.98m |
| Other Expenses | €345.17m |
| Earnings | €44.82m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 15.28% |
| Net Profit Margin | 1.76% |
| Debt/Equity Ratio | 70.7% |
How did UPR perform over the long term?
See historical performance and comparison